Skip to content

Bioorganic & Medicinal Chemistry

ISSN 1464-3391, 0968-0896

9 papers in the library · 93 citations · publishing 2003-2026

Papers

Sort Most recent Most cited

Generation of enantiospecific monoclonal antibodies against (2R,6R)-hydroxynorketamine.

Bioorganic & Medicinal Chemistry January 17, 2026 Uriel Matthew Enriquez, Natalie M González Velázquez, Mohammad Mosharraf Hossain et al.

Antibodies against small psychoactive molecules have been developed for applications ranging from substance detection and overdose protection to mechanistic understanding of the actions of complex substance mixtures. In this study, we describe the design, synthesis, formulation, and animal testing of an initial immunogenic bioconjugate, as well as subsequent isolation of enantiospecific...

DOI: 10.1016/j.bmc.2026.118573 (opens in new tab) Full text (opens in new tab) Bioconjugate chemistry Hydroxynorketamine Monoclonal antibody development

Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.

Bioorganic & Medicinal Chemistry July 15, 2015 Martin Hansen, Stine Engesgaard Jacobsen, Shane Plunkett et al. 35 citations

N-Benzyl substitution of phenethylamine 5-HT2A receptor agonists has dramatic effects on binding affinity, receptor selectivity and agonist activity. In this paper we examine how affinity for the 5-HT2A/2C receptors are influenced by N-benzyl substitution of 4-bromo-2,5-dimethoxyphenethylamine derivatives. Special attention is given to the 2' and 3'-position of the N-benzyl as such compounds...

DOI: 10.1016/j.bmc.2014.12.011 (opens in new tab) Full text (opens in new tab) 5-ht2a agonists N-benzyl phenethylamines Selectivity Structure activity relations +13

Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.

Bioorganic & Medicinal Chemistry July 1, 2014 Mark A Tepper, Robert B Zurier, Sumner H Burstein

Ajulemic acid, a side-chain analog of Δ(8)-THC-11-oic acid, was designed as a potent therapeutic agent free of the psychotropic adverse effects typical of most cannabinoids. Subsequent studies of ajulemic acid have yielded widely divergent findings on the occurrence of these adverse effects. To help resolve these discrepancies, we have prepared highly purified ajulemic acid using a different...

Semisynthetic neoclerodanes as kappa opioid receptor probes.

Bioorganic & Medicinal Chemistry May 1, 2012 Kimberly M Lovell, Tamara Vasiljevik, Juan J Araya et al. 35 citations

Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as...

New aporphinoid 5-HT2A and α1A antagonists via structural manipulations of nantenine.

Bioorganic & Medicinal Chemistry August 18, 2011 Sandeep Chaudhary, Shashikanth Ponnala, Onica Legendre et al.

A series of C1, C2, C3 and N6 analogs of nantenine (2) was synthesized and evaluated in 5-HT(2A) and α(1A) receptor functional assays. Alkyl substitution of the C1 and N6 methyl groups of nantenine provided selective 5-HT(2A) and α(1A) antagonists, respectively. The C2 alkyloxy analogs studied were generally selective for α(1A) versus 5-HT(2A). The C3 bromo analog 15 is one of the most potent...

DOI: 10.1016/j.bmc.2011.08.019 (opens in new tab) Full text (opens in new tab) Aporphines Receptors, adrenergic, alpha-1 Receptor, serotonin, 5-ht2a Structure-activity relationship

Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor.

Bioorganic & Medicinal Chemistry February 1, 2009 Cécile Béguin, Katharine K Duncan, Thomas A Munro et al.

In an effort to find novel agents which selectively target the kappa opioid receptor (KOPR), we modified the furan ring of the highly potent and selective KOPR agonist salvinorin A. Introduction of small substituents at C-16 was well tolerated. 12-epi-Salvinorin A, synthesized in four steps from salvinorin A, was a selective partial agonist at the KOPR. No clear SAR patterns were observed for...

New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.

Bioorganic & Medicinal Chemistry October 1, 2005 David Y W Lee, Zhongze Ma, Lee-Yuan Liu-Chen et al.

Bioactivity-guided fractionation of the leaves of Salvia divinorum has resulted in the isolation of three new neoclerodane diterpenoids: divinatorin D (1), divinatorin E (2), and salvinorin G (3), together with 10 known terpenoids, divinatorin C (4), hardwickiic acid (5), salvinorin-A (6), -B (7), -C (8), -D (9), -E (10), and -F (11), presqualene alcohol (12), and (E)-phytol (13). The...

Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes.

Bioorganic & Medicinal Chemistry March 20, 2003 Daniele Passarella, Raffaele Favia, Alessandra Giardini et al. 23 citations

Synthesis of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes by cycloaddition and subsequent cross-coupling reaction is described. Binding affinity of these novel compounds towards the characteristic receptorial targets of ibogaine is illustrated.